Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Liabilities (2020 - 2023)

Historic Total Liabilities for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $27.0 million.

  • Candel Therapeutics' Total Liabilities fell 1776.46% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 1776.46%. This contributed to the annual value of $30.0 million for FY2022, which is 1958.27% up from last year.
  • As of Q3 2023, Candel Therapeutics' Total Liabilities stood at $27.0 million, which was down 1776.46% from $27.9 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Total Liabilities ranged from a high of $37.8 million in Q1 2022 and a low of $12.8 million during Q4 2020
  • For the 4-year period, Candel Therapeutics' Total Liabilities averaged around $28.4 million, with its median value being $27.9 million (2023).
  • In the last 5 years, Candel Therapeutics' Total Liabilities surged by 9608.89% in 2021 and then tumbled by 2702.12% in 2023.
  • Quarter analysis of 4 years shows Candel Therapeutics' Total Liabilities stood at $12.8 million in 2020, then skyrocketed by 96.09% to $25.1 million in 2021, then grew by 19.58% to $30.0 million in 2022, then decreased by 9.8% to $27.0 million in 2023.
  • Its last three reported values are $27.0 million in Q3 2023, $27.9 million for Q2 2023, and $27.6 million during Q1 2023.